88
Views
26
CrossRef citations to date
0
Altmetric
Original Research

The clinical significance of CXCL5 in non-small cell lung cancer

, , , , &
Pages 5561-5573 | Published online: 21 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Francesca Simoncello, Giulia Maria Piperno, Nicoletta Caronni, Roberto Amadio, Ambra Cappelletto, Giulia Canarutto, Silvano Piazza, Silvio Bicciato & Federica Benvenuti. (2022) CXCL5-mediated accumulation of mature neutrophils in lung cancer tissues impairs the differentiation program of anticancer CD8 T cells and limits the efficacy of checkpoint inhibitors. OncoImmunology 11:1.
Read now
Xianguang Bai, Ming Yi, Xichao Xia, Shengnan Yu, Xinhua Zheng & Kongming Wu. (2018) Progression and prognostic value of ECT2 in non-small-cell lung cancer and its correlation with PCNA. Cancer Management and Research 10, pages 4039-4050.
Read now
Xinhua Zheng, Qian Liu, Ming Yi, Shuang Qin & Kongming Wu. (2018) The regulation of cytokine signaling by retinal determination gene network pathway in cancer. OncoTargets and Therapy 11, pages 6479-6487.
Read now

Articles from other publishers (23)

Yafeng Liu, Jiawei Zhou, Jing Wu, Xin Zhang, Jianqiang Guo, Yingru Xing, Jun Xie, Ying Bai & Dong Hu. (2023) Construction and Validation of a Novel Immune-Related Gene Pairs-Based Prognostic Model in Lung Adenocarcinoma. Cancer Control 30, pages 107327482211502.
Crossref
Zheng-zheng Wang, Xiao-ting Li, Qing-jun Li & Jin-xue Zhou. (2022) Targeting CXCL5 in Pancreatic Cancer Cells Inhibits Cancer Xenograft Growth by Reducing Proliferation and Inhibiting EMT Progression. Digestive Diseases and Sciences 68:3, pages 841-851.
Crossref
Tiantian Wu, Wannian Yang, Aiqin Sun, Zhixiao Wei & Qiong Lin. (2022) The Role of CXC Chemokines in Cancer Progression. Cancers 15:1, pages 167.
Crossref
Xin Ge, Jun He, Lin Wang, Lei Zhao, Yifang Wang, Gang Wu, Wenjing Liu, Yongqian Shu, Wei Gong, Xin-Liang Ma, Yajing Wang, Bing-Hua Jiang & Ling-Zhi Liu. (2022) Epigenetic alterations of CXCL5 in Cr(VI)-induced carcinogenesis. Science of The Total Environment 838, pages 155713.
Crossref
Jonathan Hernandez, Michael A. Turner, Prerna Bali, Mojgan Hosseini, Michael Bouvet, Kaitlyn Kelly & Marygorret Obonyo. (2022) Genomically Silent Refractory Gastric Cancer in a Young Patient Exhibits Overexpression of CXCL5. Current Oncology 29:7, pages 4725-4734.
Crossref
D. I. Murashka, A. D. Tahanovich, M. M. Kauhanka, O. V. Gotko & V. I. Prokhorova. (2022) On the issue of diagnostic value of determining the level of receptors and their ligands in blood in non-small cell lung cancer. Russian Clinical Laboratory Diagnostics 67:5, pages 277-285.
Crossref
Jie Deng, Xuejiao Ma, Yang Ni, Xiaomin Li, Wenjing Xi, Minqi Tian, Xing Zhang, Manyu Xiang, Wanglong Deng, Chao Song & Hao Wu. (2022) Identification of CXCL5 expression as a predictive biomarker associated with response and prognosis of immunotherapy in patients with non‐small cell lung cancer . Cancer Medicine 11:8, pages 1787-1795.
Crossref
永钦 汪. (2022) Research Progress on the Mechanism of Action of DACH1 in Various Tumorigenesis. Advances in Clinical Medicine 12:03, pages 2125-2130.
Crossref
Jue Wang, Ting Hu, Qiong Wang, Renwang Chen, Yuxiu Xie, Haiyan Chang & Jing Cheng. (2021) Repression of the AURKA-CXCL5 axis induces autophagic cell death and promotes radiosensitivity in non-small-cell lung cancer. Cancer Letters 509, pages 89-104.
Crossref
Nese Unver. (2021) Identification of the dominant angiogenic CXCL class chemokines associated with non-small cell lung cancer via bioinformatics tools. Medical Oncology 38:6.
Crossref
He Tian, Liyu Wang, Yu Liu, Yalong Wang, Yujia Zheng, Tao Fan, Bo Zheng, Fengwei Tan, Qi Xue, Shugeng Gao, Chunxiang Li & Jie He. (2021) Bioinformatics Analyses Reveals a Comprehensive Landscape of CXC Chemokine Family Functions in Non-Small Cell Lung Cancer. BioMed Research International 2021, pages 1-34.
Crossref
Lena Horvath, Bernard Thienpont, Liyun Zhao, Dominik Wolf & Andreas Pircher. (2020) Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC) - novel approaches and future outlook. Molecular Cancer 19:1.
Crossref
Jie Meng, Rui Su, Yun Liao, Yanyan Li & Ling Li. (2020) Identification of 10 Hub genes related to the progression of colorectal cancer by co-expression analysis. PeerJ 8, pages e9633.
Crossref
Apolonia Novillo, María Gaibar, Alicia Romero-Lorca, María Fuencisla Gilsanz, Laura Beltrán, Miguel Galán, Beatriz Antón, Diego Malón, Amalia Moreno & Ana Fernández-Santander. (2020) Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports . World Journal of Gastroenterology 26:16, pages 1979-1986.
Crossref
Wen Zhang, Huishan Wang, Mingyang Sun, Xueting Deng, Xueru Wu, Yilan Ma, Mengjing Li, Said Maisam Shuoa, Qiang You & Lin Miao. (2020) CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target. Cancer Communications 40:2-3, pages 69-80.
Crossref
Shengnan Yu, Ming Yi, Linping Xu, Shuang Qin, Anping Li & Kongming Wu. (2020) CXCL1 as an Unfavorable Prognosis Factor Negatively Regulated by DACH1 in Non-small Cell Lung Cancer. Frontiers in Oncology 9.
Crossref
Zujun Que, Bin Luo, Zhiyi Zhou, Changsheng Dong, Yi Jiang, Lin Wang, Qihui Shi & Jianhui Tian. (2019) Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo. Cancer Cell International 19:1.
Crossref
Charles S. Tannenbaum, Patricia A. Rayman, Paul G. Pavicic, Jin Sub Kim, Wei Wei, Alexandra Polefko, Wesley Wallace, Brian I. Rini, Gareth Morris-Stiff, Daniela S. Allende, Thomas Hamilton, James H. Finke & C. Marcela Diaz-Montero. (2019) Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs. Cancer Immunology Research 7:10, pages 1687-1699.
Crossref
Ziqian Li, Jiawang Zhou, Junjie Zhang, Shiying Li, Hongsheng Wang & Jun Du. (2019) Cancer‐associated fibroblasts promote PD‐L1 expression in mice cancer cells via secreting CXCL5. International Journal of Cancer.
Crossref
Matthew N. Clemenzi, Leigh Wellhauser, Makram E. Aljghami & Denise D. Belsham. (2019) Tumour necrosis factor α induces neuroinflammation and insulin resistance in immortalised hypothalamic neurones through independent pathways. Journal of Neuroendocrinology 31:1, pages e12678.
Crossref
Binwu Hu, Huiqian Fan, Xiao Lv, Songfeng Chen & Zengwu Shao. (2018) Prognostic significance of CXCL5 expression in cancer patients: a meta-analysis. Cancer Cell International 18:1.
Crossref
Yan Zhou, Galina V. Shurin, Hua Zhong, Yuri L. Bunimovich, Baohui Han & Michael R. Shurin. (2018) Schwann Cells Augment Cell Spreading and Metastasis of Lung Cancer. Cancer Research 78:20, pages 5927-5939.
Crossref
Qian Liu, Anping Li, Shengnan Yu, Shuang Qin, Na Han, Richard G. Pestell, Xinwei Han & Kongming Wu. (2018) DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis. Journal of Hematology & Oncology 11:1.
Crossref